BOHECO Success Story: College Friends to ₹2 Crore Revenue

Can seven college friends really change how a misunderstood plant fits into people’s lives and policy? We ask because this is not just a startup tale — it's a mix of lab work, field grit, and neighbourhood conversations. 🌱

In 2010, a road trip in Margaret River sparked an idea. By 2013, the team had formed a company while still holding day jobs. They began with licensed seed and fibre collection in Uttarakhand and early textile revenue of ₹30 lakh.

The founders split roles — R&D, strategy, finance, ops, marketing, legal — and built a CSIR-NBRI lab in Lucknow to standardize low-THC seeds. A later CSIR-IIIM licence let them study medicinal cannabis for pain, epilepsy and cancer.

What follows is precise: product lines, state partners, labs, and a seed-to-shelf play that moved a brand from fringe to market trust. We’ll show numbers, partners, and the team moves that mattered. Expect facts, not hype. 😊

Key Takeaways

• Seven founders turned a 2010 spark into a formal company by 2013, balancing day jobs and research.

• Early wins: Uttarakhand licences, ₹30 lakh textile revenue, and standardized low-THC seeds via a CSIR lab.

• 2017 marked clinical research licences and ₹1 crore revenue — credibility through science.

• Funding from notable investors fuelled scale and product development.

• The playbook: prove with research, build trust with products, and educate the market and policy makers.

Why this case matters for the hemp business Indian landscape

What began as a lab curiosity quickly became a test case for policy and product design. This example shows how narrative, science, and regulation can turn a marginal crop into a credible market.

The global cannabis sector is booming — roughly US$28 billion today and forecast to approach US$197.74 billion by 2028. By contrast, India's hemp market is small today (about US$2–3 million) but is projected to grow to US$500–700 million. That gap is the opportunity.

Search intent: understanding the impact

You want to know how one case shifted consumer views and nudged governments. It did that by proving compliance pathways under the NDPS Act and by creating clear labeling for products.

Context: an inflection point for the industry

• States such as Uttarakhand led cultivation; UP, Odisha and Rajasthan followed.

• More states are debating reforms, and businesses are preparing supply chains.

• The plant’s versatility—fibre, seed, oil, medicine—means multiple models can scale with research and regulation.

Bottom line: narrative + science + policy engagement can unlock a new consumer category. We’re watching an industry move from stigma to clarity. 🔑

The inciting incident: from a road trip to a market thesis

A family drive through Western Australia quietly rewired a founder’s idea of what a plant could do for communities. In Margaret River, Jahan Peston Jamas watched shops, mills and small makers build livelihoods around fibre and oils.

That sight led him back to Mumbai with a simple question: can this model work at home? He and six HR College friends treated the idea like a thesis — two intense years of research while holding day jobs.

"Perception changes when people can touch a product and see regulated pathways," — a guiding line that shaped their market thesis.

The team reframed cannabis from taboo to practical: fibre, seeds, oil, and other products with clear, compliant use cases. They sketched a roadmap: start where the plant already grows, work with farmers, and standardize supply chains.

• The spark: market proof in Margaret River.

• The approach: product + data to beat stigma.

• The outcome: a tested idea ready to become Bombay Hemp, step by step. 🚗🌿

Founders and formation: seven friends, one Bombay Hemp Company

They didn’t just form a firm — they mapped a full value chain and divided ownership from day one. That clarity made hard choices easier. The HR College cohort (class of 2011) formalized the company in 2013.

The HR College cohort and roles across R&D, strategy, finance, and supply chain

Avnish Pandya leads R&D and the science work. Jahan Peston Jamas handles strategy and partnerships—often called Peston Jamas in notes.

Sanvar Oberoi runs finance and digital systems. Yash Kotak owns market entry and media. Sumit Shah keeps operations and supply chain humming.

Chirag Tekchandaney builds brand and HR culture. Delzaad Deolaliwala manages accounting and legal.

• Seven founders, one mission: standardize hemp with care.

• Function-first org design reduced handoffs and sped decisions.

• This team setup let the company act like an integrated engine from day one. 👥

The takeaway: in a regulated category, team architecture is a strategic asset that shapes how the business scales.

Problem-solution fit: standardizing seeds and supply for industrial hemp

If you want an industry, you start with predictable genetics, not hopeful harvests. We saw farmers avoid planting when seed quality meant legal risk. That gap killed supply before it began.

So we built a lab that did real work.

Low-THC genetics: targeting 0.3–0.5% THC

Researchers aimed to stabilise a seed that kept THC between 0.3–0.5%. That range makes the crop compliant and useless for recreational misuse. Predictable genetics also means steady yields for farmers.

Innovation lab with CSIR and NBRI in Lucknow

In 2015–16 we set up a research partnership with CSIR and NBRI in Lucknow, Uttar Pradesh. The lab collected and evaluated about 150 wild seed varieties.

• Core fix: a research-led breeding program for cultivation industrial needs.

• Standardised seeds were offered to farmers at nominal rates to kickstart planting.

• Result: a supply base that feeds early products and builds policymaker trust.

“Science turned field risk into a repeatable farm plan.”

Building science-led credibility: partnerships and research

Regulatory approval in 2017 opened doors to clinical research and institutional partnerships. That licence let the team legally grow and study cannabis for medical use. It moved the work from lab notes to formal trials.

Licensing with CSIR-IIIM to study medicinal cannabis

We partnered with CSIR-IIIM in 2017 to study cannabis as a potential medicine. The licence covered cultivation and controlled experiments. This gave the company legal standing and laboratory rigor.

Therapeutic focus: pain, epilepsy, cancer, and more

The initial research targeted India-first priorities: pain relief, epilepsy, cancer, and sickle cell anemia. These areas had limited affordable options, so the work aimed at cost-effective treatments. Health outcomes were measured, not marketed as claims.

First right to commercialize research outcomes

The company supplies raw materials and genetics to partner programs while holding the first right to commercialize any successful product. Cross-border seed collaborations (China, Romania, Italy, France) broadened genetic diversity and boosted trials.

• Credibility is built in the lab with compliant licences.

• Public research + startup agility speeds translation to product.

• Data, IP and protocols create a durable moat for future medicines. 🧪

Changing the conversation: advocacy, policy, and public narrative

Changing minds started with carry-on samples—actual products that made abstract policy real. We took hemp shoes, fabrics, and bricks into meetings so officials could touch outcomes, not just hear claims.

Engagements with policymakers focused on NDPS Act nuances. We worked with ministry stakeholders and industry bodies to show how controlled cultivation and clear labeling reduce legal risk.

Conferences and myth-busting

The 2018 CSIR event put scientists, doctors, and the Union Minister of State on one stage. That forum drew the line between medical and recreational use. It helped calm policymakers and gave researchers a public platform.

• Policy is proof—real samples make arguments tangible.

• NDPS nuances mean states can enable regulated cultivation.

• For the consumer, the brand answered “Will I get high?” with facts and light humour.

• Engaging governments early built allies and eased scale-up.

"Context and compliance are everything." — peston jamas

The message to people was simple: cannabis can be medicine and material when framed correctly. Advocacy became category infrastructure, not just PR. 🏛️

States opening doors: Uttarakhand’s lead and others following

One state’s leap of faith started a ripple that other states began to test. Uttarakhand was the first to permit large-scale, controlled cultivation under NDPS safeguards. That move gave farmers a clear permit path and a model for local administration.

Emergence of controlled, regulated cultivation across states

Following Uttarakhand, Uttar Pradesh, Odisha, and Rajasthan moved quickly to enable pilot projects. Himachal Pradesh publicly signalled its intent. Madhya Pradesh and Manipur are exploring frameworks now.

• Proof point: a single state can enable compliant cultivation and reduce legal risk.

• Momentum: multiple states are adopting templates for licenses and THC thresholds.

• Why it matters: Governments see rural livelihoods and industry growth as a twin benefit.

"Controlled cultivation frameworks—licenses, clear THC limits and defined end-uses—are the backbone of scaling."

Each new state adds a different climate, farmer base, and processing edge. As more regions join, supply becomes predictable and downstream products can scale. This is steady, compliance-first growth—one patch of fields at a time. 🌱

Vertical integration in action: from seed to shelf

Vertical integration turned scattered village work into a repeatable supply engine. We built a clear path so a licensed seed becomes a saleable product on a rack.

Seed sourcing, breeding, and farmer enablement

Licensed teams collected wild seeds under permission and trained village groups to pick and rett. That field work fed a seed breeding program that aimed to standardize cultivation.

Farmer enablement meant short training, simple contracts, and guaranteed offtake. This reduced risk at the farm gate and kept raw material quality high.

Processing: retting, fiber to yarn, and fabric

Retting separates fibre from stalks. Bart fibre went to weaving units that spun yarn and made fabric. Designers and distributors turned bolts into market-ready products sold through textile lines.

Early revenue proved the model: ₹30 lakh from clothing showed the supply chain could generate money while R&D matured.

Why this matters: Controlling the supply chain de-risks compliance. When you manage seed, fibre, and processing, the company can scale with confidence. The result is a resilient ecosystem that learns and compounds value. 🔗

Textile playbook: Hemp Fabric Lab, HempTex India, and B Label

A focused textile playbook turned lab-grade fibre into garments people wanted to wear. We built three engines that each solve a part of the value chain.

Hemp Fabric Lab is a fabric marketplace for designers. It lets creators touch samples and test blends quickly.

HempTex India scales yarn manufacturing. The mill produces hemp-blended yarns for mills and brands.

B Label is the consumer-facing brand that carries wardrobe staples with clear tags and an education line.

Chirag Tekchandaney led the visual voice and positioning so that product, brand, and story read as one.

• Three textile engines: HFL for creators, HempTex for yarn, B Label for retail.

• Fibre mixes: pure hemp where it performs; hemp-cotton and hemp-jute for feel and strength.

• Designer and distributor partner networks speed market feedback and reach.

Why it matters: products that wear well normalize the plant. The Bombay hemp textile ecosystem shows how verticalization de-risks category creation and helps the material move quietly from field to fashion. 👗

Health, wellness, and nutrition portfolio

A practical wellness line grew from field-tested seeds into simple daily routines for pain, sleep, and stress.

We blend Ayurvedic knowledge with lab-led research to make remedies that speak to the Endocannabinoid System (ECS). These Ayurvedic cannabis formulations target common issues—pain, sleep and stress—with clear guidance on use.

Ayurvedic remedies and ECS-aligned products

Some items are OTC. Others require a practitioner’s note and are treated as medicine with prescriptions. We work with Ayurveda doctors to keep treatment safe and clear.

Hemp seed oil and the Himalayan nutrition range

Hemp seed oil anchors the basket. The nutrition range adds Himalayan seeds, protein blends, omegas, and minerals for daily use.

• Farm outputs become drizzles, capsules, and drops for easy routines.

• Guidance is practical—how much, how often (per month plans), and what to expect.

• Plant-first: minimal processing, transparent labels, and plain-English education beside each SKU.

"Traditional wisdom, backed by research, for modern habits."

Our goal is simple: products that feel familiar, work reliably, and build a sustainable habit stack for you and the planet. 🥗

Revenue, funding, and growth milestones

Revenue and capital moves turned an experimental label into a measurable market force. Early textile sales of ₹30 lakh proved the demand and helped the company refine products and channels.

By FY2017, the firm hit ₹1 crore in revenue. That year it served 5,060 unique clients and ran with 18 employees. These numbers gave the team credible traction with both consumers and the government.

Funding followed proof. A US$1M seed round in 2016 (including Ratan Tata) set the stage. Angel and industry leaders then backed a larger raise—US$2M Series A—to scale textiles, wellness and research verticals.

Notable backers included:

• Ratan Tata

• Rajan Anandan

• MA Tejani

• Srinivaas Sirigeri

• Singularity Ventures

By FY2020, revenues reached ~₹3 crore as hemp seed oil and nutrition ranges expanded. Two farmer groups matured the seeds-to-shelf supply, while practitioner tie-ups and clear labeling boosted repeat purchase.

Why this matters: capital + clear metrics let leaders like Yash Kotak, Peston Jamas, Chirag Tekchandaney, and Sumit Shah keep execution tight. The blended growth—revenue, funding, and policy engagement built a repeatable path for the team and the market. 📈

Social impact in the hills: livelihoods and inclusion

In Rudraprayag, a few trained hands turned fibre into steady pay.

Sunita Devi from Dewali village learned to weave stoles and shawls after training with Mandakini Mahila Bunker Samiti. Her income reportedly tripled to ₹5,300 per month. That number matters—it's cash that pays for food, school, and health.

Weaver incomes and women-led micro-enterprises

NGOs handled training. The company secured offtake and steady fibre flows. Together, they created dignified work, not charity.

• Real impact shows up in households—more money per month and more control for women.

• People-first value chains turn skills into small-scale businesses that last.

• The state-level enablement meets village enterprise policy and ground action align.

• Fibre becomes income; yarn becomes agency—each woven piece is a livelihood step.

"Consistent orders and fair pricing changed how villages view farming and craft."

This model is teachable. When markets are structured, communities co-create value. And when you visit Dewali, you see the change in smiles and savings. 🤝

Sustainability edge: hemp versus conventional fibers

Choosing the right fibre matters — for farmers, factories, and the climate. We look at hard numbers so you can decide what to wear and why it matters.

Water and yield first: a hemp shirt needs roughly 180 gallons of water versus cotton’s ~720 gallons. That’s a big gap for regions where water is scarce.

Yields tell a similar story. Hemp fibre averages about 220–367 kg per acre. Cotton ranges from 54–201 kg. More fibre per acre means more output for less land.

Water, pesticides, yield, and multi-use benefits

• Less water, fewer chemicals: Hemp needs fertilizers but generally not heavy pesticides. Cotton uses about 26% of global pesticides.

• Higher fibre per acre: more material with lower land pressure and simpler processing.

• Multi-use plant: seeds and flowers add nutrition and wellness products, so fields deliver several revenue streams.

• Emerging research: studies explore bio-fuel and new applications that widen the sustainability moat.

• Compliance matters: cultivation tuned for low THC keeps farmers secure and markets clear.

"Material choices powered by data—less water, fewer chemicals, and higher utility across products."

For the industry under pressure to decarbonize, this material offers a research-backed alternative. For you, it means clothing and products that match values with impact. 🌎

Boheco's success story: a blueprint for India’s hemp business

What looks like a brand lift is a layered strategy of education, research, and on-the-ground work. We did three things at once: teach regulators, train farmers, and ship thoughtful products that make the idea tangible.

Narrative-led market creation

Tell the why, then show the how. Conferences, demos, and clear labels let people touch the claim. Partnerships with CSIR, NBRI, and IIIM gave scientific weight. Textile verticals (Hemp Fabric Lab, HempTex, B Label) turned fibre into desirable wearables.

Risk navigation in a regulated category

Compliance was treated as a feature, not a tax. Licences, documentation and transparent supply chains reduced legal friction. We trained farmers, standardized seeds, and kept traceability visible at each step.

"Products teach better than pamphlets—each SKU demystifies the plant and process."

• The blueprint blends research, farmer enablement and design into one business model.

• Market trust comes from regulators and delighted consumers speaking the same language.

• Partnerships lend authority; creators add desirability—both scale the industry.

The result: a brand that leads the market and a replicable playbook for a responsible hemp company. 🧭

Risks, competitors, and what BOHECO 2.0 could be

We face a simple test: can careful research and farmer networks outpace policy whiplash and copycats?

The NDPS framework still reads differently across states. That creates real risk for cultivation and product rollouts. Enforcement varies. One rule in Uttarakhand may look different in another state.

Policy uncertainty and emerging players

Risks are real: policy zig-zags, uneven enforcement, and shifting public opinion can slow plans.

Competition is rising. Startups like BE Hemp, Hemp Cann, and Hempster are nimble. Large names—Patanjali among them—are eyeing cannabis research. That heat validates the market but raises the stakes.

"Market validation comes with more players and more scrutiny."

Pathways: vertical spin-outs or a hemp conglomerate

Investors suggested doubling down on high-revenue verticals. Two routes make sense.

• Spin-outs: separate textiles, wellness, and genetics into focused companies to chase fast, specialised returns.

• Conglomerate: keep everything under one roof to protect the supply chain and capture cross-vertical margins.

The smart response is practical: deepen research moats, strengthen partner networks, and standardize cultivation protocols across geographies. Company resilience will hinge on supply redundancy, cross-state complianc,e and clinician-led education loops.

Bottom line: Market leadership isn’t just first-mover status. It’s constant education, safety-led innovation, and a partner network—farmers, labs, clinicians, retailers—that keeps the flywheel turning even when policy headwinds hit. 🚀

Conclusion

From lab benches to market racks, the project proved a single plant can power multiple livelihoods. Over the years, the team moved from inspiration to a multi-vertical venture backed by CSIR partnerships and state-level cultivation enablement.

Licences, labs, and farmer training turned research into real-world results. Revenues hit ₹1 crore in FY17 and ~₹3 crore by FY20, showing the approach works.

Products became proof points. Textiles, nutrition, and wellness lines taught regulators and consumers what compliant cannabis and hemp supply chains can deliver.

The key benefits ripple across sustainability and inclusion—less water, steady farmer income, and clearer choices for your closet and kitchen. The blueprint is simple: educate, cultivate, elevate.

Your takeaway: When science meets story, a taboo can become a trusted category. Keep an eye on the next chapter—more states, better genetics, smarter SKUs. And yes, the future looks green. 🌿

FAQ

What sparked the founders to start Bombay Hemp Company after a road trip?

The team saw Margaret River’s hemp economy and realized India had untapped potential. They connected the plant’s uses — fibre, seed, medicine — with local craft and textile skills. That market thesis turned into a mission: build a compliant, science-backed supply chain from seed to shelf. 🌱

How did they make industrial hemp cultivation legally viable in India?

They focused on low-THC genetics (around 0.3–0.5%) and engaged with policymakers to clarify NDPS Act nuances. Strategic research partnerships and licensing with institutions such as the CSIR helped them study compliant strains and obtain credibility to work with farmers and states. 🤝

What role did research partnerships play in their growth?

Research ties — for example, with CSIR and NBRI — enabled seed standardization, medicinal research, and first-right pathways to commercialize outcomes. This science-led approach attracted investors and eased regulatory conversations. 🔬

How did they build a reliable supply chain for fibre and seed?

They vertically integrated: breeding low-THC seeds, enabling farmers with training, and setting up processing hubs for retting and fibre-to-yarn conversion. This reduced raw material bottlenecks and ensured quality for textiles and nutrition products. 🧵

What product categories did they focus on first?

Textiles and wellness were early plays — hemp fabric blends, designer partnerships, and a nutrition line featuring hemp seed oil and hemp-based Ayurvedic formulations. They also explored medicinal research areas like pain and epilepsy. 🩺

Which Indian states were important early adopters for cultivation?

Uttarakhand led the way, followed by interest in states opening controlled cultivation frameworks. The company worked state-by-state to align with local rules and farmer programs. 🗺️

How did they work with craft communities and weavers?

By creating demand for hemp textiles and running the Hemp Fabric Lab and HempTex initiatives, they brought weavers into higher-value supply chains, supporting women-led micro-enterprises and improving mountain livelihoods. 🧶

What were the major funding and revenue milestones?

The brand scaled from small textile revenues to notable funding rounds, including a US$1M seed and a US$2M Series A, alongside investor backing from prominent industry figures. Revenue milestones reflected expansion across textiles, nutrition, and B2B supply. 📈

How did they balance medicinal research with consumer products?

They separated therapeutic research (licensed work with CSIR-IIIM) from consumer wellness lines. Clear labeling, clinical collaborations, and public education helped distinguish medical uses from lifestyle products. 🧾

What sustainability advantages did they highlight over conventional fibres?

Hemp uses less water, fewer pesticides, and offers higher multi-use yields — fibre, seed, and biomass. These points were key in brand storytelling and in pitching to eco-conscious consumers and corporate partners. ♻️

Who were the key partners in textiles and distribution?

They partnered with designers, distributors, and retail brands to create blended fabrics (hemp, cotton, jute) and to launch labeled apparel lines. Collaboration with established textile players helped scale manufacturing and market access. 👗

What regulatory risks should other entrepreneurs expect?

Policy uncertainty and differing state-level rules remain the biggest risk. Emerging competitors and the need for consistent low-THC seed quality add operational challenges. Advocating for clearer national rules is essential. ⚖️

Can hemp-based nutrition and Ayurveda work together?

Yes. Hemp seed oil and protein fit well with Ayurvedic and ECS-aligned products when formulated responsibly. Scientific validation and transparent labeling help bridge traditional remedies and modern nutrition. 🌿

How did investor interest shape scaling strategy?

Investor backing enabled expansion into labs, supply-chain infrastructure, and larger production runs. It also pushed the team to professionalize operations and pursue larger B2B contracts and global partnerships. 💼

What does a vertically integrated hemp company look like in practice?

It means owning the chain: seed breeding, farmer support, processing (retting, decortication), textile converting, product R&D, and retail or B2B sales. This reduces dependency and improves margins across lines. 🔗

Where can entrepreneurs find credible seeds and breeding expertise?

Collaborate with agri-research institutes and accredited labs. Partnering with universities or CSIR labs helps source compliant genetics and set up an innovation lab for trait selection and seed multiplication. 🌾

How did the brand handle public misconceptions about cannabis?

Through myth-busting campaigns, policy dialogues, and clear education that separates low-THC industrial varieties from recreational cannabis. Conferences and media outreach helped change the narrative. 📣

What are realistic margins and revenue paths for hemp textiles and nutrition?

Early textile runs can start small (e.g., tens of lakhs) and scale to crores with design and distribution partnerships. Nutrition and wellness carry higher margins but need strong supply and certification. Diversifying streams stabilizes cash flow. 💡

BOHECO Success Story: College Friends to ₹2 Crore Revenue

BOHECO Success Story: College Friends to ₹2 Crore Revenue